Ischemic Heart Disease

• FDA approval · 2007-10-22
  FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approves a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.

• FDA approval · 2007-09-05
  FDA Approved: CARVEDILOL — Original Application (Dr. Reddy's Laboratories Limited)

  FDA approved Carvedilol on an original application by Dr. Reddy's Laboratories Limited (generic carvedilol).

• FDA approval · 2007-08-23
  FDA Approved: AMMONIA N 13 — Original Application (THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH)

  FDA approved AMMONIA N 13 (NH3N13), an ammonia-13 radiopharmaceutical for PET imaging, derived from the original NDA submitted by The Feinst…

• CLINICAL_TRIALS trial_result · 2007-05-22
  Clinical Trial Update: The Use of Myocardial Deformation Imaging

  The RWTH Aachen University trial evaluated myocardial deformation imaging for viability in ischemic left ventricular dysfunction and predict…

• CLINICAL_TRIALS trial_result · 2007-04-11
  Clinical Trial Update: Patterns of Antiacids Use in Patients With IHD Admitted to Department of Internal Medicine

  This completed clinical trial from Rambam Health Care Campus examined patterns of antacid use among patients with ischemic heart disease adm…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2006-10-16
  Clinical Trial Update: Revascularization in Heart Failure Trial - REHEAT 2 [Phase 4]

  Clinical trial update for the REHEAT 2 Phase 4 study evaluating revascularization strategies in ischemic heart disease, including patients w…

• CLINICAL_TRIALS trial_result · 2006-09-12
  Clinical Trial Update: Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study) [Phase 4]

  Phase 4 LE MANS study comparing unprotected left main stenting versus bypass surgery has completed; no outcome results are provided in this …

• FDA approval · 2006-07-27
  FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)

  The FDA approved a supplemental application for TOPROL XL (metoprolol succinate) from Melinta Therapeutics, LLC. The approval updates the pr…